Amirose London Holdings Plc (LSE:ALH) is one of the smallest and quietest companies on the Aquis Stock Exchange Growth Market, yet the questions hanging over it are sizeable. A Norfolk contract manufacturer that reached the market through a reverse Takeover of a former Cryptocurrency shell in June 2025, Amirose reported 40% Revenue growth in its first interim period as a listed business, added a fragrance-industry veteran to its board in May 2026, and is approaching the deadline for its first full-year results as an enlarged group.
With the lock-in on its four largest shareholders expired, a Nicky Clarke Manufacturing contract due to be generating revenue, and a factory still running below capacity, the coming months will show whether the growth story that justified the listing is translating into profit.
Latest development: boardroom hire and share allotment on 5 May 2026
The most recent material announcements came on 5 May 2026, when Amirose appointed David Crickmore as a non-executive director and, separately, issued 375,678 additional shares to an investor under previously agreed subscription terms, taking the total in issue to 122,047,543.
Crickmore brings more than 45 years' experience across luxury goods, beauty, fragrance and fashion, including 25 years as chief executive in branded fragrance and bath-and-body manufacturing. He led fragrance house Amouage between 2006 and 2019, taking it into around 75 markets, and later scaled the Thameen Brand into roughly 70.
The board said the appointment "materially strengthens Amirose's Leadership capability" and would support its "long-term growth ambitions and international expansion strategy". Crickmore, who holds 1.95% of the company, said he looked forward to supporting "the Company's next phase of growth and transformation". Pairing an export-focused beauty executive with a factory that has spare capacity is the clearest signal yet of where management wants to take the business. No trading update has followed the interim results of 29 December 2025.
Business overview: contract manufacturing for premium personal care brands
Amirose London Ltd, the operating subsidiary, is a contract manufacturer serving the personal care sector from a BRC and ISO 22716-certified Facility in Thetford, Norfolk. It offers formulation development, packaging sourcing, bulk manufacturing, filling and distribution across bath and body, hair care, fragrance, shaving and sun care products. At the June 2025 admission it employed 86 people and served around 75 customers across more than 200 brands.
The company reached the market through File Forge Technology Plc, a shell that had briefly pivoted towards the Filecoin ecosystem in 2024. Completion of the reverse takeover on 6 June 2025 involved the issue of 117,483,865 shares at 5p, giving a Market Capitalisation of £5.87m at admission, alongside a modest £310,500 raised by subscription and placing.
Ownership is highly concentrated. According to the company's investor page, Howard White, chairman Aleksandra Binkowska, Ben White and non-executive director Mitchell Field together control roughly 84% of the Equity through Epoque, leaving a public holding of about 15.6%.
Financial performance: revenue up 40%, but a loss in the first half
The most meaningful figures are the unaudited interim results for the six months to 30 September 2025, published on 29 December 2025. Revenue rose to £7.19m from £5.13m in the comparable period of 2024, growth of about 40%. Gross Profit increased to £2.45m from £1.87m, although gross Margin slipped to around 34% from roughly 36%.
The group nevertheless recorded an operating loss of £552,000, against £243,000 a year earlier, and a loss after tax of £507,000, or 0.55p per share. Binkowska attributed the loss "mostly" to the reverse takeover: the underlying trading loss at Amirose London Ltd was £69,000, with £152,000 of plc and listing costs and a £286,000 non-cash reverse Acquisition adjustment making up the balance.
The Balance Sheet is thin. Cash stood at £149,680 at 30 September 2025, up from £11,023 at 31 March 2025, while trade payables of £2.67m dominated total Assets of £3.47m, leaving net assets of £803,764. No Dividend was paid.
For context, the admission announcement cited revenue of £12.7m and profit of £38,800 for the year to 30 March 2024, and draft revenue of about £11m with breakeven EBITDA for the year to 30 March 2025. The "final results" of 30 September 2025 covered only the pre-acquisition shell.
What could drive the stock next?
The nearest scheduled catalyst is the first full-year results for the enlarged group, covering the year to 31 March 2026. Aquis Growth Market rules require audited accounts within six months of the year end, implying publication by the end of September 2026, although no date has been announced. These will show whether second-half trading turned the small underlying loss into profit and how much cash the Business generated.
The Nicky Clarke hair care contract, announced on 10 July 2025 with distributor Three Pears, was expected to start contributing revenue towards the end of the year to March 2026 and to exceed £1m in the year to March 2027, with launches scheduled for early 2026. Confirmation that the range has launched on time would validate the strategy of filling spare capacity through brand partnerships. Crickmore's appointment points to an international push, and any overseas customer win would be a notable step for a largely UK-focused business.
Risks investors should watch
Liquidity is the most obvious concern. With around 84% of the shares held by four connected parties and a public float of roughly 15%, trading on the Aquis Access segment is likely to be sparse and prices volatile. The 12-month lock-in agreed at admission has now expired.
The financial position leaves little margin for error. Cash of under £150,000 at the half-year and trade payables of £2.67m suggest dependence on supplier terms and tight working-capital management. A downturn in orders could quickly require additional funding, and any issue near the 5p admission price would dilute minority shareholders.
Gross margin declined in the first half despite higher volumes, and the company itself has warned that "heightened geopolitical instability, persistent trade frictions, and uncertain macroeconomic conditions continue to weigh heavily on international commerce". Disclosure has also been light, with no trading update in the eight months since the interims.
Outlook
Amirose London Holdings is a small but real business, with a certified factory, a long customer list and demonstrated revenue growth, wrapped in a micro-cap listing that carries the costs of being public. The interims showed the Top Line moving in the right direction, with the loss mostly attributable to one-off listing and accounting effects.
The forthcoming annual results to 31 March 2026 will be the first genuine test: whether underlying profitability has returned, whether Nicky Clarke has begun to Fill the factory, and whether cash has improved from a very low base. Until then, the thin float, concentrated ownership and modest balance sheet mark the shares out as highly speculative.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...